Search research articles
Contact Us
Filters
Showing results (181-190 of 321) with videos related to
Page
of 33
Sort By:
Psychopharmacology
|
January 1, 1991
Interaction of haloperidol and SCH 23390 with cocaine and dopamine receptor subtype-selective agonists on schedule-controlled behavior of squirrel monkeys
J M Witkin, C W Schindler, S R Tella, et al.
Molecular Microbiology
|
October 1, 1992
An SOS-inducible defective retronphage (phi R86) in Escherichia coli strain B
J Kirchner, D Lim, E M Witkin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1987
Recovery from ultraviolet light-induced inhibition of DNA synthesis requires umuDC gene products in recA718 mutant strains but not in recA+ strains of Escherichia coli
E M Witkin, V Roegner-Maniscalco, J B Sweasy, et al.
European Journal of Pharmacology
|
October 3, 1994
Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors
S Izenwasser, P Terry, B Heller, et al.
The International Journal of Neuropsychopharmacology
|
January 12, 2010
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm
Severine Farley, Kalliopi Apazoglou, Jeffrey M Witkin, et al.
Pharmacology, Biochemistry, and Behavior
|
April 1, 1989
Atropine effects on delayed discrimination performance of rats
T F Elsmore, J K Parkinson, J R Leu, et al.
Southern Medical Journal
|
July 1, 1986
Heterophilic antibody as a source of error in immunoassay
L R Witherspoon, M Witkin, S E Shuler, et al.
Life Sciences
|
January 1, 1991
Effects of cocaine alone and in combination with haloperidol and SCH 23390 on cardiovascular function in squirrel monkeys
C W Schindler, S R Tella, J M Witkin, et al.
Lancet (London, England)
|
July 8, 1989
Potential toxic interactions of cocaine and mazindol
J H Jaffe, J M Witkin, S R Goldberg, et al.
Expert Opinion on Drug Discovery
|
August 8, 2022
Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism
Andrzej Pilc, Agata Machaczka, Paweł Kawalec, et al.
Page
of 33
Search research articles
Search
Showing results (181-190 of 321) with videos related to
Sort By:
Page
of 33
Psychopharmacology
|
January 1, 1991
Interaction of haloperidol and SCH 23390 with cocaine and dopamine receptor subtype-selective agonists on schedule-controlled behavior of squirrel monkeys
J M Witkin, C W Schindler, S R Tella, et al.
Molecular Microbiology
|
October 1, 1992
An SOS-inducible defective retronphage (phi R86) in Escherichia coli strain B
J Kirchner, D Lim, E M Witkin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1987
Recovery from ultraviolet light-induced inhibition of DNA synthesis requires umuDC gene products in recA718 mutant strains but not in recA+ strains of Escherichia coli
E M Witkin, V Roegner-Maniscalco, J B Sweasy, et al.
European Journal of Pharmacology
|
October 3, 1994
Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors
S Izenwasser, P Terry, B Heller, et al.
The International Journal of Neuropsychopharmacology
|
January 12, 2010
Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm
Severine Farley, Kalliopi Apazoglou, Jeffrey M Witkin, et al.
Pharmacology, Biochemistry, and Behavior
|
April 1, 1989
Atropine effects on delayed discrimination performance of rats
T F Elsmore, J K Parkinson, J R Leu, et al.
Southern Medical Journal
|
July 1, 1986
Heterophilic antibody as a source of error in immunoassay
L R Witherspoon, M Witkin, S E Shuler, et al.
Life Sciences
|
January 1, 1991
Effects of cocaine alone and in combination with haloperidol and SCH 23390 on cardiovascular function in squirrel monkeys
C W Schindler, S R Tella, J M Witkin, et al.
Lancet (London, England)
|
July 8, 1989
Potential toxic interactions of cocaine and mazindol
J H Jaffe, J M Witkin, S R Goldberg, et al.
Expert Opinion on Drug Discovery
|
August 8, 2022
Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism
Andrzej Pilc, Agata Machaczka, Paweł Kawalec, et al.
Page
of 33